baber/WOPTO huggingface dataset:
Patent DK-0450693-T3 (DK)
Inventor: JONES DAVID RUSSEL
IPC: F16L59/02
Filed: 1991-03-20
Granted: 1996-03-11
Abstract: A foam formulation, useful in the preparation of water-blown heat-insulating material, comprising (i) one or more polyols, (ii) one or more organic polyisocyanates, (iii) water, and (iv) auxiliary materials known in the art, characterized in that the polyol or polyol mixture has an average functionality (Fn) varying from 2.7 to 4.3; a hydroxyl value (OHv) of 325 to 500 mg KOH/g, and a viscosity measured at 20  DEG C of between 350 mPa.s and 2300 mPa.s; the use of said polyol or polyol mixture as softening point improver in a process of preparing water-blown heat-insulating material, and the water-blown heat-insulating material so prepared.
Patent DK-0512916-T3 (DK)
Inventor: OSTRO MARC J
IPC: A61P9/00
Filed: 1992-05-06
Granted: 1999-09-20
Abstract: A method of treating a cell activation/adhesion syndrome in mammals, including humans, by the administration of a prostaglandin associated with a liposome is disclosed. Such cell activation/adhesion syndromes may include reperfusion injury, septic shock, myocardial infarction, adult respiratory distress syndrome, rheumatoid vasculitis, systemic vasculitis, lupus, post traumatic shock, burn injury or restenosis after angioplasty. In a preferred embodiment, the prostaglandin is encapsulated in the liposomes.
Patent DK-0528757-T3 (DK)
Inventor: LUESSI ANDRE
IPC: A47J31/40
Filed: 1992-07-28
Granted: 1996-01-22
Abstract: The brewing device comprises a brewing cylinder (9) having a cylindrical bore (10) in which a lower plunger (8) is arranged so as to be freely movable and longitudinally displaceable. An upper plunger (7) is firmly connected to a frame (1). Parallel to the vertically arranged brewing cylinder (9) there is a drive spindle (6) which has guiding means (23). A carrier member (24) connected to the brewing cylinder has further guiding means (25) which are engaged with those of the drive spindle (6). By rotating the drive spindle (6) in one direction or the other, the brewing cylinder is moved upwards or downwards. The brewing cylinder is filled with ground coffee via a funnel (12) which can be pivoted out. In order to determine the quantity of ground coffee contained, the brewing cylinder is moved upwards under time control, at least until a counter force produced by the upper plunger (7) over the compressed ground coffee is as great as the driving force of the spindle. In order to allow the preferred brewing of loose ground coffee, the brewing chamber formed between the two plungers (7, 8) is slightly enlarged again before the actual brewing operation. The device is distinguished particularly by its simple construction with few parts subject to wear, the simple construction being enhanced by the omission of limiting switches as a result of the complete time control of the drive spindle. <IMAGE>
Patent DK-0577733-T3 (DK)
Inventor: GRIFFIN RICHARD C
IPC: C04B26/12
Filed: 1992-03-09
Granted: 1996-06-03
Abstract: A vibratable, castable refractory composition containing a refractory aggregate, a liquid resol-phenolic ester-cured resin, which can be an aqueous mixture, and an ester is disclosed. The composition may further contain an activating agent to promote ambient temperature curing of the resin by the formation of ester-phenolic polymer bonds; an anti-oxidant metal powder as a strengthener; a slag penetration resistance agent; and a wetting aid and dispersant. Cast refractory components made from the composition exhibit great flexural and compressive strength. The composition and shapes cast therefrom are suitable for use in high temperature refractory applications in reducing or inert atmospheres as are encountered in the ferrous industries.
Patent DK-0599857-T3 (DK)
Inventor: MERKENICH KARL
IPC: A23C19/05
Filed: 1992-07-08
Granted: 1995-04-18
Abstract: PCT No. PCT/EP92/01533 Sec. 371 Date Aug. 15, 1994 Sec. 102(e) Date Aug. 15, 1994 PCT Filed Jul. 8, 1992 PCT Pub. No. WO93/03623 PCT Pub. Date Mar. 4, 1993.The invention concerns the use of acidic sodium polyphosphates and Maddrell's salt for the production of natural cheese, processed cheese and cheese preparations which have a P2O5 content of 73-77 wt. %, on Na2O content of 20-25 wt. %, a water content of 2-3 wt. % and an average linear degree of condensation of 8-20. Preferred are the polyphosphates which are present as comparatively long chains (catena compounds) which are possible cross-linked and contain sodium metaphospbates (tri- and tetra-phosphates) in below 2 wt. %.
Patent DK-0579111-T3 (DK)
Inventor: GNAUERT WERNER
IPC: F16K11/02
Filed: 1993-07-08
Granted: 1996-02-26
Abstract: To improve a single-lever mixing valve with an operating handle (2) designed as a head part, the head part being received by an adjusting lever (11) projecting from the valve housing and being fastened to it, a flange element (3), over which a part of the operating handle designed as a cap (20) can be placed and wedged radially to provide a positive and frictional connection, can be fastened to the adjusting lever. <IMAGE>
Patent DK-0576366-T3 (DK)
Inventor: DUBOIS JEAN-MARIE
IPC: C23C4/08
Filed: 1993-05-18
Granted: 1996-07-29
Abstract: The finishes of the present invention consist essentially of metal alloys having the general formula: TaCrbZrcBdMeM'fXgIh(I) in which a+b+c+d+e+f+g+h=100 atomic percent; T is Ni, Co, Ni-Co or any combination of at least one of Ni and Co with Fe, wherein 3<Fe<82 at. % and 3<a<85 at. %; M is one or more elements of the group consisting of Mn, Cu, V, Ti, Mo, Ru, Hf, Ta, W, Nb, Rh, wherein 0<e<12 at. %; M' is one or more rare earths, including Y, wherein 0<f<4 at. %; X is one or more metalloids of the group consisting of C, P, Ge and Si, wherein 0<g<17 at. %; I represents inevitable impurities, wherein h<1 at. %, and 5</=b</=25, 5</=c</=15, and 5</=d</=18. Powders obtained from these alloys that are deposited on substrates by thermal projection provide finishes having increased hardness in addition to high ductility and excellent resistance to corrosion. The finishes are suited for applications including hydraulic equipment.
Patent DK-0611281-T3 (DK)
Inventor: SINGER NORMAN S
IPC: A23L15/00
Filed: 1993-05-12
Granted: 1999-09-13
Abstract: The present invention provides improvements in supercritical fluid extraction of particulate egg substrates by forming the substrate into porous solid particles characterized by a number weighted mean particle size ranging from about 0.5 millimeters to about 3 millimeters and by a tapped bulk density of from about 0.2 to about 0.5 grams per milliliter prior to subjecting the substrate to extraction under supercritical conditions.
Patent DK-0651630-T3 (DK)
Inventor: KAWAI NORIKO
IPC: A61F13/15
Filed: 1993-07-22
Granted: 1999-08-16
Abstract: The present invention relates to absorbent articles such as sanitary napkins worn by women. More particularly, the present invention relates to absorbent articles, such as thin sanitary napkins, that are stretchable, especially in the longitudinal direction.
Patent DK-0636364-T3 (DK)
Inventor: GOWAN JR WALTER G
IPC: A61K9/20
Filed: 1994-07-27
Granted: 2000-10-09
Abstract: The present invention relates to a compressed pharmaceutical dosage form containing pharmaceutical particles coated with a taste-masking composition, a water-disintegratable, compressible carbohydrate and a binder. These components are dry blended and compressed into a dosage form, such as a tablet, having a hardness sufficient to cause the carbohydrate to disintegrate within 30 seconds after oral administration, thereby allowing the coated particles to be swallowed.
Patent DK-0697866-T3 (DK)
Inventor: BERRY STEPHEN
IPC: A61K47/26
Filed: 1994-05-10
Granted: 2000-04-17
Abstract: Mycophenolate mofetil and mycophenolic acid can be conveniently manufactured into high dose oral formulations by the hot melt filling of a supercooled mycophenolate mofetil or mycophenolic acid liquid into a pharmaceutical dosage form. High dose oral pharmaceutical formulations and manufacturing methods therefor are disclosed.
Patent DK-0706380-T3 (DK)
Inventor: HATA TAKEHISA
IPC: A61K9/48
Filed: 1994-06-28
Granted: 2001-10-08
Abstract: PCT No. PCT/JP94/01043 Sec. 371 Date Jan. 2, 1996 Sec. 102(e) Date Jan. 2, 1996 PCT Filed Jun. 28, 1994 PCT Pub. No. WO95/01166 PCT Pub. Date Jan. 12, 1995This invention relates to an encapsulated pharmaceutical dosage form comprising a practically insoluble compound or salt and an intracapsular fluid, and/or a surfactant and/or cellulose derivative. It provides for increased oral absorption as compared with the conventional system because, on release of capsule contents from the capsule shell, the practically insoluble compound or salt undergoes diminution in crystal size.
Patent DK-0714304-T3 (DK)
Inventor: LIST HARALD
IPC: A61K9/70
Filed: 1994-08-10
Granted: 2000-10-16
Abstract: PCT No. PCT/EP94/02650 Sec. 371 Date Jun. 27, 1996 Sec. 102(e) Date Jun. 27, 1996 PCT Filed Aug. 10, 1994 PCT Pub. No. WO95/05829 PCT Pub. Date Mar. 2, 1995A therapeutic system for topically administering active substances for the treatment of skin diseases involving severe cell proliferation is characterized in that the active substance is a pharmaceutically acceptable derivate of vitamin D3, with the exception of such derivates as serve to regulate the calcium metabolism.
Patent DK-0673913-T3 (DK)
Inventor: CARCASONA ALFONS DR RER NAT
IPC: A61K31/19
Filed: 1995-03-18
Granted: 1999-09-20
Abstract: Calcium alkali metal citrates of formula CaXC6H5O7 (I), where X = alkali metal, and their hydrates are new. Also claimed are pharmaceutical compsns. contg. (I).
Patent DK-0710549-T3 (DK)
Inventor: FEHRING KARL-HEINZ
IPC: B32B27/30
Filed: 1995-10-26
Granted: 2000-10-02
Abstract: Lamination of polymethacrylate plastics (I) by thermal bonding of at least 2 surface-heated layers comprises passing the layers (1), which are preheated to surface temps. of 130-200 degrees C on the side (1a) to be bonded, whilst retaining their original shape, between a pair of rollers (2,3), at least one (3) of which exerts pressure (4), at a rate of 5-200 mm/s and pressure of 10-500 N. Pref. the difference between the surface temp. and core temp. of the layer is at least 20, esp. at least 50 K. Flat or elongated inserts may be incorporated, which have thicknesses of up to 50, esp. up to 25% of the thickness of the (I) layers and cover at most 90% of the bonding area. Alternatively, the bonding surface may be engraved or imprinted to a depth of at least 0.2, esp. at least 1 mm so that the laminate has 3D inclusions of definite shape. The layers (1) are sheets or films and are 0.5-100, esp. 1-50 mm thick, 0.1-2 m wide and 0.1-5 m long. The polymer contains at least 50, esp. at least 80 wt.% methyl methacrylate (MMA) units. The flat inserts consist of thermoplastic elastomers; and the elongated inserts are wires, steel coils or filaments, esp. plastics filaments with high elasticity and high modulus.
Patent DK-0785926-T3 (DK)
Inventor: KLING ANDREAS
IPC: C07D405/12
Filed: 1995-10-07
Granted: 2001-10-08
Abstract: Heterocyclyl-substd. propanoic acids and their derivs., of formula (I), are new. R = formyl, tetrazolyl, nitrile, COOH or a gp. that can be hydrolysed to COOH; X = N or CR14; R2 = H, OH, NH2, alkylamino, dialkylamino, halo, alkyl, haloalkyl, alkoxy, haloalkoxy or alkylthio; R14 = H or 1-5 C alkyl; R3 = R2 or alkoxyimino; or CR3 + CR14 = 5 or 6 membered alkylene or alkenyl ring (opt. substd. by 1-2 alkyl) in which a methylene can be replaced by O, S, NH or alkylamino; R4, R5 = phenyl or naphthyl (both opt. substd. by one or more halo, NO2, CN, OH, alkyl, haloalkyl, alkoxy, haloalkyloxy, phenoxy, alkylthio, NH2, alkylamine or dialkylamino) or 3-7 C cycloalkyl; or the phenyl or naphthyl gps. are opt. bonded at the O- position (by a bond, CH2, O, S, SO2, ethylene, ethenylene or opt. alkylated amino); R6 = H, 1-8 C alkyl, 2-6 C alkenyl, 3-6 C alkynyl, 3-8 C cycloalkyl (all opt. substd. by 1 or more halo, NO2, CN, alkoxy 3-6 C alkenyloxy, 3-6 C alkynyloxy, alkylthio, haloalkoxy, alkylcarbonyl, alkoxycarbonyl, 3-8 C alkylcarbonylalkyl, alkylamino, dialkylamino, phenyl, Ph or OPh), Ar or Het; Y = S, O or bond; Q = S, O, SO, SO2 or bond; Ph = substd. phenyl, where substits. are halo, NO2, CN, alkyl, haloalkyl, alkoxy, haloalkoxy or alkylthio; Ar = phenyl or naphthyl (both opt. substd. by 1 or more halo, NO2, CN, OH, NH2, alkylamino, dialkylamino or OCH2CH2O); Het = 5 or 6 membered heteroaromatic with 1-3 N atoms and/or one S or O (opt. substd. by 1-4 halo and/or 1 or 2 alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, phenyl, phenoxy or phenyl carbonyl (where the phenyl is opt. substd. by 1-5 halo and/or 1-3 alkyl, haloalkyl, alkoxy, haloalkoxy and/or alkylthio)); alkyl and alkoxy have 1-4 C unless otherwise stated; provided that R6 is not H when Q = bond.
Patent DK-0801059-T3 (DK)
Inventor: HIROKAWA YOSHIMI
IPC: A61K31/40
Filed: 1995-11-27
Granted: 2001-09-24
Abstract: An indole derivative of the formula: <CHEM> wherein R1 is lower alkoxy, lower alkoxycarbonyl-lower alkoxy, carboxy-lower alkoxy , lower alkoxycarbonyl, phenyl-lower alkoxy, lower alkyl being optionally substituted by hydroxy, di-lower alkylaminosulfonyl, etc., R2 is hydrogen, halogen, lower alkoxy, lower alkoxycarbonyl-lower alkoxy, carboxy-lower alkoxy, etc., R3 is hydrogen or lower alkyl, R4 is halogen or trifluoromethyl, R5 is lower alkyl, or a salt thereof, these compounds being potent  beta 3-adrenergic receptor-stimulating agent with excellent adrenoceptor selectivity, and being useful in the prophylaxis or treatment of obesity or diabetes mellitus.
Patent DK-0861293-T3 (DK)
Inventor: CITTADINI PAOLO
IPC: C09K3/10
Filed: 1995-12-16
Granted: 2002-12-16
Abstract: PCT No. PCT/EP95/05061 Sec. 371 Date Jun. 18, 1997 Sec. 102(e) Date Jun. 18, 1997 PCT Filed Dec. 16, 1995 PCT Pub. No. WO96/19534 PCT Pub. Date Jun. 27, 1996Gaskets especially for refrigerators are made from a polymeric material consisting of a mixture comprising a-olefin copolymers. The gaskets obtained therefrom are lighter, thinner and have better mechanical characteristics than those of the known art.
Patent DK-0836427-T3 (DK)
Inventor: TORRIE PAUL A
IPC: A61B17/04
Filed: 1996-06-05
Granted: 2005-01-10
Abstract: A suture passing forceps includes an axially elongated support shaft, and a first suture holder for removably holding a needled suture and a second suture holder for capturing the needled suture. The first suture holder includes a suture inlet through which at least part of the suture can be passed. The first suture holder or the second suture holder is an actuatable member which pivots toward an operating position to capture the needled suture in the second suture holder and pivots away from the operating position to remove the suture from the first suture holder. The suture inlet in the suture holder enables complete removal of the suture from the suture holder when the actuatable member and the needled suture move away from the operating position. The second suture holder includes a holding region defined by a contoured surface permitting the needled suture to slide within the holding region.
Patent DK-0831787-T3 (DK)
Inventor: BERNSTEIN HOWARD
IPC: A61K38/27
Filed: 1996-06-03
Granted: 2001-12-17
Abstract: A composition, and methods of forming and using said composition, for the sustained release of biologically active, stabilized human growth hormone (hGH). The sustained release composition of this invention comprises a polymeric matrix of a biocompatible polymer and particles of biologically active, stabilized hGH, wherein said particles are dispersed within the biocompatible polymer. The method of the invention for producing a composition for the sustained release of biologically active hGH, includes dissolving a biocompatible polymer in a polymer solvent to form a polymer solution, dispersing particles of biologically active, metal cation-stabilized hGH in the polymer solution, and then solidifying the polymer to form a polymeric matrix containing a dispersion of said hGH particles. The method for using a composition of the invention is a method for providing a therapeutically effective blood level of biologically active, non-aggregated hGH in a subject for a sustained period. In this method, a subject is administered an effective dose of the sustained release composition of the present invention. The method of using the sustained release composition of the present invention comprises providing a therapeutically effective blood level of biologically active, non-aggregated human growth hormone in a subject for a sustained period by administering to the subject a dose of said sustained release composition.
Patent DK-0847365-T3 (DK)
Inventor: BODE JENS
IPC: B65D1/32
Filed: 1996-08-22
Granted: 2000-07-31
Abstract: PCT No. PCT/EP96/03694 Sec. 371 Date Mar. 19, 1998 Sec. 102(e) Date Mar. 19, 1998 PCT Filed Aug. 22, 1996 PCT Pub. No. WO97/08058 PCT Pub. Date Mar. 6, 1997A packing container for liquid products comprises a closure which opens and closes automatically when the pressure in the container varies, such that the container is easy to handle irrespective of its filling level and can be reliably secured to a wall or the like. The container also includes at least one flat side wall for securing it to a flat surface, and at least one concave or convex actuation surface in the region of opposing side walls such that the user can apply manual pressure.
Patent DK-0850298-T3 (DK)
Inventor: SINDEN JOHN INSTITUTE OF PSYCH
IPC: A61K35/30
Filed: 1996-09-12
Granted: 2003-09-15
Abstract: The subject invention pertains to a novel method of correction of behavioral and/or psychological deficits made possible by the intracerebral transplantation of pluripotent neuroepithelial cells. Cells, cell lines, pharmaceutical preparations, medicaments, methods for the production and maintenance of the cell lines for use in the method of the invention are encompassed by the invention.
Patent DK-0901379-T3 (DK)
Inventor: MCFADDEN D GRANT
IPC: A61P35/00
Filed: 1997-05-21
Granted: 2000-12-27
Abstract: The present invention provides a method of use for a novel chemokine binding protein (type-2 CBP) encoded by poxviruses and having amino acid sequence homology with the Shope fibroma virus T1 family of proteins against disease syndromes associated with acute or chronic dysregulated inflammatory responses.
Patent DK-0925418-T3 (DK)
Inventor: APPELTANS GUY
IPC: E05G1/14
Filed: 1997-08-26
Granted: 2001-04-02
Abstract: The invention concerns a protective device for valuable documents, including a volume capable of being closed and divided into two compartments, one of the compartments being used to receive the documents to be protected while in the second compartment caps contain a pyrotechnic mixture which, when the device is wrongly manipulated, will burst into a flame which will penetrate the documents in the first mentioned compartment.
Patent DK-0988060-T3 (DK)
Inventor: LICHA KAI
IPC: A61K41/00
Filed: 1998-04-02
Granted: 2007-10-15
Abstract: The invention relates to acid-labile and enzymatically divisible compounds for in-vivo and in-vitro diagnosis by means of near infrared radiation (NIR-radiation), the use of said compounds as optic diagnostic and therapeutic agents, and the diagnostic agents containing said compounds.
Patent DK-1014169-T3 (DK)
Inventor: ABE TAKASHI
IPC: G03B21/62
Filed: 1999-12-23
Granted: 2006-06-26
Abstract: A liquid crystal rear-projection TV screen has a double-side lens sheet (20) and horizontal lenticular sheet (30). A vertical lenticular portion (23) is disposed on the rear side of the double-side lens sheet (20), and Fresnel lens (22) is disposed on the front side. A horizontal lenticular portion (32) is disposed on the rear side of the horizontal lenticular sheet (30), and a light-shielding layer (35) and protective resin substrate (41) are disposed on the front side. The resin substrate (21) of the double-side lens sheet (20) has a low transmittance, and the resin substrates (31, 41) of the horizontal lenticular sheet have high transmittances. The observer recognizes an image on the double-side lens sheet (20) arranged behind the light-shielding layer (35). <IMAGE>   <IMAGE>
Patent DK-1112095-T3 (DK)
Inventor: RASCHKE MICHAEL DR
IPC: A61L31/08
Filed: 1999-09-10
Granted: 2003-03-17
Abstract: This invention relates to an implant for treating pathological changes in the spinal column and/or locomotor system. According to one embodiment of the invention, the implant has a surface, a body, and an enamel-like or varnish-like coating that is up to 100 μm thick, comprises a biodegradable polymer such as polylactide which has a mean molecular weight of 100 kDa or less, forms an adhesive bond to the surface of the body such that when the implant is implanted, mechanical friction will not abrade or damage the coating, and is adapted to contact bone when implanted. This coating has an osteoinductive effect, which promotes the healing of fractures. Additional osteoinductive materials such as growth factors may be incorporated in the coating. The invention also relates to a method for producing such an implant using the following steps: preparing a dispersion of a biodegradable polymer in an organic solvent; applying the dispersion on the surface to be coated; and allowing the organic solvent to evaporate.
Patent ES-2219213-T3 (ES)
Inventor: BAUMANN MARKUS
IPC: C02F3/12
Filed: 2000-02-25
Granted: 2004-12-01
Abstract: A small-scale waste water treatment plant is installed within a single basin which holds a number of aggregate units. These include an aerator (52), a clear water extractor pump (56), a water level indicator, a low-level sludge agitator, and a water sampler (62, 64). The aggregate units are held either all or in part within a common housing (38, 102) which is inserted into and may be withdrawn from the basin.
Patent ES-2275458-T3 (ES)
Title: Inyector de combustible.
Inventor: MATTIOLI MASSIMO
IPC: F02M51/06
Filed: 2000-03-24
Granted: 2007-06-16
Abstract: Inyector (1) de combustible, que comprende: un cuerpo (2) tubular principal dotado con al menos un conducto (3) de paso que termina en una boquilla (3a) pulverizadora adaptada para atomizar el combustible contenido en el conducto (3) de paso; un elemento (4) de obturación que se mueve en el conducto (3) de paso desde y hasta una posición cerrada, en la que el elemento (4) de obturación está dispuesto colindando con respecto a la boquilla (3a) pulverizadora, cerrándola de tal manera que evita cualquier descarga de combustible; y medios (8) de amortiguador del tipo fluidodinámico adaptado para frenar el elemento (4) de obturación durante su retorno a la posición cerrada; en el que el elemento de obturación comprende un casquillo (6) montado para moverse axialmente dentro del conducto (3) de paso, y un pasador (7) de cierre que se extiende desde el casquillo (6) hacia la boquilla (3a) pulverizadora; el pasador (7) de cierre está conectado de manera rígida al casquillo (6); y la punta del pasador (7) de cierre está adaptada para disponerse colindando con la boquilla (3a) pulverizadora cuando el elemento (4) de obturación está en la posición cerrada, de modo que evite cualquier descarga de combustible; en el que el casquillo (6) define, dentro del conducto (3) de paso, cámaras (9b) y (9a) primera y segunda de volumen variable que son complementarias; la segunda cámara (9a) de volumen variable se comunica externamente a través de la boquilla (3a) pulverizadora; y el medio (8) de amortiguador del tipo fluidodinámico comprende una válvula (10) de una sola vía proporcionada en el cuerpo del casquillo (6) y adaptada para permitir que el fluido fluya solamente desde la primera cámara (9b) de volumen variable hasta la segunda (9a); el inyector (1) se caracteriza porque la válvula (10) de una sola vía comprende un conducto (12) de flujo de combustible que se extiende a través del cuerpo del casquillo (6) paralelo al eje (A), y una placa (13) flexible sujeta al casquillo (6) dentro de la segunda cámara (9a), de modo que cierra, en la posición de reposo, la entrada del conducto (12) de flujo de combustible.